Zimmer Biomet Announces Third Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
Go back to Zimmer Biomet Announces Third Quarter 2024 Financial Results
October 31, 2024 12:37 PM EDT
Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $117.00 (from $112.00) while maintaining a Hold rating.
The analyst comments "ZBH's 3Q cc rev beat offset by ~90bps op margin miss; in-line EPS benefited from non-operating items and... More
October 30, 2024 4:28 PM EDT
Oppenheimer analyst Steven Lichtman reiterated an Outperform rating and $135.00 price target on Zimmer Biomet (NYSE: ZBH).
The analyst comments "3Q24 sales of $1.824B (+4.1% constant-currency) outpaced our/Street's $1.791B/$1.795B on less ERP headwind than expected and better than expected underlying performance, particularly in SET. Knees... More
October 30, 2024 6:34 AM EDT
(Updated - October 30, 2024 6:37 AM EDT)
Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.74, in-line with the analyst estimate of $1.74. Revenue for the quarter came in at $1.82 billion versus the consensus estimate of $1.8 billion.
GUIDANCE:
Zimmer Biomet Holdings... More
